Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £11.23 per share on 15 July 2009, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $35.12 per ADR on 9 July 2009, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 9 July 2009.
|
Ordinary shares |
ADRs |
Mr A P Witty |
257.27 |
|
Mr J S Heslop |
0.01 |
|
Dr M M Slaoui |
150.59 |
|
Mrs C E Bruck Slaoui |
44.52 |
|
Mr S M Bicknell |
79.93 |
|
Mr J M Clarke |
156.50 |
|
Mr M Dunoyer |
96.89 |
|
Mr E J Gray |
170.99 |
|
Mr D Learmouth |
46.44 |
|
Mr W C Louv |
|
49.11 |
Mr D J Phelan |
|
135.42 |
Dr D Pulman |
|
78.33 |
Mr D S Redfern |
74.19 |
|
Ms C Thomas |
56.35 |
|
Mr J R Stéphenne |
458.80 |
|
The Company was advised of this information on 17 July 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
17 July 2009